These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22999193)

  • 21. Cardiovascular disease in kidney transplant recipients: the prognostic value of inflammatory cytokine genotypes.
    La Manna G; Cappuccilli ML; Cianciolo G; Conte D; Comai G; Carretta E; Scolari MP; Stefoni S
    Transplantation; 2010 Apr; 89(8):1001-8. PubMed ID: 20061995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene polymorphism association studies in dialysis: the nutrition-inflammation axis.
    Stenvinkel P; Pecoits-Filho R; Lindholm B;
    Semin Dial; 2005; 18(4):322-30. PubMed ID: 16076356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding cardiovascular disease through the lens of genome-wide association studies.
    Arking DE; Chakravarti A
    Trends Genet; 2009 Sep; 25(9):387-94. PubMed ID: 19716196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population.
    Cummings DM; King DE; Mainous AG; Geesey ME
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):180-5. PubMed ID: 16575270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From candidate gene to genome-wide association studies in cardiovascular disease.
    Gianfagna F; Cugino D; Santimone I; Iacoviello L
    Thromb Res; 2012 Mar; 129(3):320-4. PubMed ID: 22154244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia.
    Ravaglia G; Forti P; Maioli F; Servadei L; Martelli M; Arnone G; Talerico T; Zoli M; Mariani E
    Exp Gerontol; 2004 Mar; 39(3):443-50. PubMed ID: 15036404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Waist circumference is related to low-grade inflammation in youth.
    Steene-Johannessen J; Kolle E; Reseland JE; Anderssen SA; Andersen LB
    Int J Pediatr Obes; 2010 Aug; 5(4):313-9. PubMed ID: 20078378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
    Suzuki T; Nagai R
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
    [No Abstract]   [Full Text] [Related]  

  • 31. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?
    Rao M; Jaber BL; Balakrishnan VS
    Semin Dial; 2006; 19(2):129-35. PubMed ID: 16551290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum markers of vascular inflammation in dyslipemia.
    Francisco G; Hernández C; Simó R
    Clin Chim Acta; 2006 Jul; 369(1):1-16. PubMed ID: 16469304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causality can be shown with mendelian randomization. Cardiovascular risk relations tested with the method].
    Nilsson PM
    Lakartidningen; 2013 Apr 17-23; 110(16):832-5. PubMed ID: 23717930
    [No Abstract]   [Full Text] [Related]  

  • 34. Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease.
    Thanassoulis G
    Can J Cardiol; 2013 Jan; 29(1):30-6. PubMed ID: 23199790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice.
    Avan A; Tavakoly Sany SB; Ghayour-Mobarhan M; Rahimi HR; Tajfard M; Ferns G
    J Cell Physiol; 2018 Nov; 233(11):8508-8525. PubMed ID: 29932219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating miRNAs: messengers on the move in cardiovascular disease.
    Egea V; Schober A; Weber C
    Thromb Haemost; 2012 Oct; 108(4):590-1. PubMed ID: 22955179
    [No Abstract]   [Full Text] [Related]  

  • 37. From circulating biomarkers to genomics and imaging in the prediction of cardiovascular events in the general population.
    Fava C; Montagnana M; Guidi GC; Melander O
    Ann Med; 2012 Aug; 44(5):433-47. PubMed ID: 21623699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation and incident cardiovascular disease.
    Westerman KE; Ordovás JM
    Curr Opin Clin Nutr Metab Care; 2020 Jul; 23(4):236-240. PubMed ID: 32487875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of genetic and environmental factors on protein biomarkers for common non-communicable disease and use of personally normalized plasma protein profiles (PNPPP).
    Enroth S; Bosdotter Enroth S; Johansson Å; Gyllensten U
    Biomarkers; 2015; 20(6-7):355-64. PubMed ID: 26551787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional profiling to identify biomarkers of disease and drug response.
    Mendrick DL
    Pharmacogenomics; 2011 Feb; 12(2):235-49. PubMed ID: 21332316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.